Dexcom
+3

Mar 17, 2026
•
2 min read
During the conference, Dexcom showcased upcoming device updates, new platform features, and future innovations designed to expand and enhance its CGM ecosystem.
News
+3

Mar 13, 2026
•
2 min read
Approximately 1.5% of Omnipod 5 pods are impacted by a tubing issue that may cause insulin to leak inside the device.
CGM
+1

Mar 12, 2026
•
2 min read
The collaboration allows Accu-Chek's CGM data to flow into the Glooko platform, giving care teams a single dashboard to review glucose trends in select European markets.
News
+4

Mar 12, 2026
•
3 min read
Results from the EVOLUTION 2 trial presented at ATTD showed 68% time in range using a fully closed-loop system—with no mealtime boluses and minimal time below range.
News
+2

Mar 11, 2026
•
3 min read
Sequel Med Tech's insulin pump moves beyond its limited release with new integrations and wider access for users and clinicians across the United States.
News
+2

Mar 10, 2026
•
3 min read
The new Liberty feature allows people with type 1 diabetes to temporarily stop counting carbs or deliver boluses while CamAPS FX automatically manages glucose levels.
News
+3

Mar 5, 2026
•
2 min read
The world's smallest tubed AID system can now be controlled from Android phones, unlocking a massive untapped market.
CGM
+2

Mar 3, 2026
•
3 min read
The company behind the Eversense implantable CGM is one step closer to releasing a next-gen sensor that removes the requirement for an external transmitter.
News
+1

Mar 3, 2026
•
3 min read
A warning letter to Unomedical raises concerns about leaking infusion sets used with insulin pumps from Medtronic, Tandem Diabetes Care, and Beta Bionics.
News
+4

Feb 23, 2026
•
3 min read
The new model is meant to lower upfront costs and expand access, joining the broader industry move toward subscription-style pump access through pharmacies.
CGM
+1

Feb 18, 2026
•
4 min read
The device has a customizable 7-inch display designed to display up to six CGM readings at one time making it great for people with diabetes.
News
+2

Feb 17, 2026
•
2 min read
The first patients have received its investigational Portal Insulin as development moves toward larger trials in 2027.
News
+3

Feb 12, 2026
•
2 min read
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
News
+2

Feb 11, 2026
•
2 min read
The company has began production of validation lots for its tubeless insulin pump aimed at “almost‐pumpers,” with plans for an early 2026 commercial debut still on track.
Dexcom
+2

Feb 9, 2026
•
3 min read
Dexcom's G7 Trends tab offers users more diabetes insights, showcasing time in range, sensor usage, and key metrics, with more insights expected in the future.
News
+3

Feb 6, 2026
•
4 min read
Insulet's highly anticipated data platform, Omnipod Discover, is available to healthcare providers and Omnipod users across the Middle East.